Reliability and Diagnostic Thresholds for Ultrasound Measurements of Dermal Thickness in Breast Lymphedema

Elizabeth S. Dylke, Helen Benincasa Nakagawa, Lanni Lin, Jillian L. Clarke, and Sharon L. Kilbreath. LYMPHATIC RESEARCH AND BIOLOGY Volume 00, Number 00, 2017

Click to read the abstract

Reliability and Diagnostic Thresholds for Ultrasound Measurements of Dermal Thickness in Breast Lymphedema

Elizabeth S. Dylke, Helen Benincasa Nakagawa, Lanni Lin, Jillian L. Clarke, and Sharon L. Kilbreath. LYMPHATIC RESEARCH AND BIOLOGY Volume 00, Number 00, 2017

Background: Lymphedema of the breast, secondary to treatment for breast cancer, is difficult to assess due to the shape of the breast and the nature of the tissue. Ultrasound measurement of dermal thickness has been previously used to assess breast swelling; however, the reliability of the measurements, or what should be considered an abnormal thickness, is currently known.

Methods and Results: Thirty-eight women with breast edema were recruited and underwent assessment using ultrasound. During the assessment, the four quadrants (superior, inferior, medial, and lateral) of the affected and unaffected breasts were imaged three times each. Dermal thickness was then measured by two assessors, on two occasions for each captured image. The interimage, intrarater, and inter-rater reliability was all found to be excellent (Cronbach’s alpha=0.995; ICC(3,1)=0.962 and 0.851; and ICC(2,1)=0.977, respectively). A dermal thickness of >1.6mm in the superior and lateral quadrants and 2.0mm in the medial and inferior quadrants was determined, by receiver-operating characteristics curve analysis, as the optimal diagnostic threshold to detect breast edema.

Conclusion: Dermal thickness measurements can be reliably completed on breasts with edema secondary to breast cancer. Future study is needed to determine the utility of the dermal thickness thresholds established as well as to investigate changes in dermal thickness as a response to treatment of breast edema.

Main findings

  • The intra image reliability was excellent as the intra- and inter-rater reliability of the measurement of dermal thickness.
  • The measurement of dermal thickness was able to distinguish between breasts with and without oedema; a dermal thickness of>2mm in the medial or inferior quadrants of the breast or a dermal thickness of >1.6mm in the superior and lateral quadrant of the breast should be considered indicative of lymphedema.
  • Thickness of normal breast skin to vary between 1 and 2mm.
  • In the unaffected breast there is variation in the dermal thickness across the breast, supporting the importance of assessment of each quadrant of both the affected and unaffected breasts to determine the extent of oedema.
  • It has been suggested that ultrasound imaging can be used for measurement and evaluation of the effectiveness of treatments for breast lymphedema.
  • Future research is required to further understand the presentation of images and the relationship with clinical signs and symptoms of breast oedema.